These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2944369)

  • 21. Comparison of dobutamine and enoximone for low output states following cardiac surgery.
    Orellano L; Darwisch M; Dieterich HA; Köllner V
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S13-9. PubMed ID: 2145233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience.
    Treese N; Erbel R; Pilcher J; Choraria S; Rhein S; Dieterich HA; Meyer J
    Am J Cardiol; 1987 Aug; 60(5):85C-90C. PubMed ID: 2956876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive effects of enoximone and nitroprusside in unstable chronic heart failure.
    Treese N; Erbel R; Rhein S; Henrichs KJ; Meyer J
    Eur Heart J; 1989 Jun; 10(6):484-92. PubMed ID: 2527155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term enoximone therapy in unstable chronic heart failure.
    Treese N; Rhein S; Erbel R; Meyer J
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S78-83. PubMed ID: 2480491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
    Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
    Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
    Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
    Choraria SK; Taylor D; Pilcher J
    Circulation; 1987 Dec; 76(6):1307-11. PubMed ID: 2960473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F; Peters P; Schneider M
    Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dose-response study of intravenous enoximone in congestive heart failure.
    Erbel R; Meyer J; Diefenbach C; Delorme G; Bourdarias JP; Vernant P; Lellouche D; Mattioli G; Barbieri A; Installe E
    Am J Cardiol; 1987 Aug; 60(5):31C-36C. PubMed ID: 2956865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of the effects of enoximone by a dobutamine infusion.
    Vincent JL; Madhoun P; Primo G; Kahn RJ
    Intensive Care Med; 1989; 15(8):530-1. PubMed ID: 2532656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
    Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic effects of enoximone and comparison with dobutamine in patients with chronic respiratory insufficiency and pulmonary arterial hypertension].
    Coulaud JM; Faitg R; Poler F; Rezgui N; Besse B; Lissac J
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():51-6. PubMed ID: 2147835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of enoximone versus tobutamine in the treatment of low cardiac output after cardiac surgery].
    Lançon JP; Caillard B; Volot F; Obadia JF; Bock F
    Ann Fr Anesth Reanim; 1990; 9(3):289-94. PubMed ID: 2142589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous use of enoximone.
    Crawford MH
    Am J Cardiol; 1987 Aug; 60(5):42C-45C. PubMed ID: 2956867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response.
    Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
    J Am Coll Cardiol; 1985 Jun; 5(6):1414-21. PubMed ID: 3158689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enoximone].
    Ventura G
    Medicina (Firenze); 1990; 10(2):191-3. PubMed ID: 2148796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of oral long-term enoximone therapy on the arrhythmia profile in chronic heart failure].
    Treese N; Rhein S; Werneyer A; Erbel R; von Olshausen K; Pop T; Meyer J
    Z Kardiol; 1988 Oct; 77(10):653-9. PubMed ID: 2467449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.